ClinicalTrials.gov
public full text
Public Domain
Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients
The goal of this multicenter observational study is to determine whether preoperative statin use reduces major adverse cardiovascular events or other complications after liver transplantation. The main question it aims to answer is: Does preoperative statin use reduce major adverse cardiovascular events or other complications after liver transplantation? The records of participants who already took statins before liver transplantation will be reviewed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Statin Therapy in Heart Failure: Potential Mechanisms of Benefit#1338363
- Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trial#624816
- Effect of Statins on Trained Immunity#801577
- Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis#911564
- A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)#208347
Record · ID 1370787
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive